(Q28371403)

English

Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports

scientific article

In more languages

edit

Statements

0 references

0 references

Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports (English)

0 references

0 references

1 reference

H R Smith

1

0 references

A M Croft

series ordinal

2

0 references

M M Black

series ordinal

3

0 references

language of work or name

English

0 references

publication date

July 1999

0 references

published in

Clinical and Experimental Dermatology

0 references

volume

24

0 references

issue

4

0 references

page(s)

249-54

0 references

cites work

Kinetics of a new antimalarial, mefloquine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Mefloquine to prevent malaria: a systematic review of trials

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Mefloquine-induced Stevens-Johnson syndrome

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Exfoliative dermatitis during malarial prophylaxis with mefloquine.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Mefloquine-associated cutaneous vasculitis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Single day mefloquine-artesunate combination in the treatment of multi-drug resistant falciparum malaria.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Malaria prophylaxis. Toxicity of mefloquine is similar to that of other chemoprophylaxis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Cutaneous vasculitis associated with mefloquine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Long-term malaria chemoprophylaxis with mefloquine in Dutch marines in Cambodia.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Safety and immunogenicity of live oral cholera and typhoid vaccines administered alone or in combination with antimalarial drugs, oral polio vaccine, or yellow fever vaccine

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Fatal toxic epidermal necrolysis associated with mefloquine antimalarial prophylaxis.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Pruritus and antimalarial drugs in Africans

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Malaria prevention for travelers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2230.1999.00471.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2230.1999.00471.X

0 references

PubMed ID

10457122

0 references

ResearchGate publication ID

12843054

0 references

(Q28371403)

Dermatological adverse effects with the antimalarial drug mefloquine: a review of 74 published case reports

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)